Lauren M. Sabella, Chief Commercial Officer at ACORDA THERAPEUTICS INC (ACOR), sold 7,548 shares at $27.84 ($210K) on 2018-06-28, disclosed to the SEC on 2018-12-21.
Seasonal sale ($210k) by Chief Commercial Officer — this insider has traded ACOR in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.84 | 3,774 | $105K | 50.0% |
| 2 | $27.84 | 3,774 | $105K | 50.0% |
| Total | $27.84 avg | 7,548 | $210K | 100% |
| Filing → |
| ACOR | SELL | 2018-12-06 | $192K | — | Filing → |
| ACOR | SELL | 2018-07-02 | $163K | — | Filing → |
| ACOR | SELL | 2018-06-12 | $853K | — | Filing → |